moxifloxacin has been researched along with quinazolines in 3 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 19,235 | 2,417 | 8,835 |
Protein | Taxonomy | moxifloxacin (IC50) | quinazolines (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armstrong, P; Borer, J | 1 |
Beaufils, P; Cabanis, MJ; Extramiana, F; Leenhardt, A; Maison-Blanche, P; Ortemann-Renon, C | 1 |
Takai, N; Tanaka, Y | 1 |
1 trial(s) available for moxifloxacin and quinazolines
Article | Year |
---|---|
Clinical assessment of drug-induced QT prolongation in association with heart rate changes.
Topics: Adrenergic alpha-Antagonists; Adult; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Predictive Value of Tests; Quinazolines; Quinolines; Reproducibility of Results; Treatment Outcome | 2005 |
2 other study(ies) available for moxifloxacin and quinazolines
Article | Year |
---|---|
Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adolescent; Adult; Advisory Committees; Anti-Infective Agents; Aza Compounds; Cardiovascular Agents; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Approval; Electrocardiography; Fluoroquinolones; Humans; Imidazoles; Impotence, Vasculogenic; Male; Middle Aged; Moxifloxacin; Phosphoric Diester Hydrolases; Piperazines; Prostatic Hyperplasia; Quinazolines; Quinolines; Risk Assessment; Sulfones; Triazines; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride | 2003 |
Imaging of drug and metabolite distribution by MS: case studies.
Topics: Animals; Autoradiography; Dogs; Fluoroquinolones; Lapatinib; Liver; Lung; Mice; Moxifloxacin; Pharmaceutical Preparations; Quinazolines; Rabbits; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terfenadine; Tissue Distribution; Whole Body Imaging | 2015 |